Copyright
©The Author(s) 2022.
World J Clin Cases. Nov 16, 2022; 10(32): 12028-12035
Published online Nov 16, 2022. doi: 10.12998/wjcc.v10.i32.12028
Published online Nov 16, 2022. doi: 10.12998/wjcc.v10.i32.12028
Table 1 Laboratory examinations
Laboratory tests | Examination value | Reference value |
RBC | 4.24 × 1012 | 4.30-5.80 × 1012 |
HB | 125 g/L | 130-175 g/L |
MPV | 11.10 fL | 125-350 × 109/L |
LDH | 176.90 U/L | 120-250 U/L |
HCG | < 0.20 mIU/mL | — |
AFP | 3.09 ng/ml | 0-7.0 ng/mL |
LH | 13.10 mIU/mL | ≤ 8.6 mIU/mL |
FSH | 15.40 mIU/mL | ≤ 12.4 mIU/mL |
E | 45.90 pg/mL | 0.0-36.5 pg/mL |
PRL | 30.50 ng/mL | 2.1-17.7 ng/mL |
T | 279.00 ng/dL | 241-827 ng/dL |
ALB | 38.2 g/L | 40-55 g/L |
Table 2 Distribution of testicular neuroendocrine tumor types and sizes in 132 cases
Tumor type | Number of cases | Rate | Size (mm) | mean size (mm) |
Pure primary TNET | 101 | 76.52% | 3-100 | 41.75 |
TNET associated teratoma | 22 | 16.67% | 10-80 | 36.91 |
Secondary TNET | 9 | 6.82% | 5-60 | 22.13 |
Primary TNET associated with metastases | — | — | 5-100 | 52.70 |
Table 3 Distribution of testicular neuroendocrine tumor immunohistochemical results in 132 cases
Marker | Number of patients | Positive cases | Rate |
Cytokeratin | 29 | 27 | 93.10% |
Chromogranin | 59 | 59 | 100% |
Synaptophysin | 45 | 45 | 100% |
PLAP | 20 | 0 | 0 |
Serotonin | 15 | 13 | 86.67% |
NSE | 14 | 14 | 100% |
p53 | 11 | 0 | 0 |
CD56 | 7 | 7 | 100% |
Vimentin | 6 | 5 | 83.30% |
Inhibin | 4 | 0 | 0 |
TTF 1 | 3 | 1 | 33.33% |
AFP | 2 | 0 | 0 |
- Citation: Xiao T, Luo LH, Guo LF, Wang LQ, Feng L. Primary testicular neuroendocrine tumor with liver lymph node metastasis: A case report and review of the literature. World J Clin Cases 2022; 10(32): 12028-12035
- URL: https://www.wjgnet.com/2307-8960/full/v10/i32/12028.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v10.i32.12028